Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Assets (2016 - 2025)

National Healthcare's Assets history spans 16 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Assets changed 0.13% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, changed 0.13%, while the annual FY2025 figure was $1.5 billion, 0.13% changed from the prior year.
  • Assets reached $1.5 billion in Q4 2025 per NHC's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $1.6 billion in Q3 2025 to a low of $1.3 billion in Q1 2023.
  • Average Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2021.
  • Peak YoY movement for Assets: decreased 9.12% in 2022, then rose 21.9% in 2024.
  • A 5-year view of Assets shows it stood at $1.4 billion in 2021, then dropped by 9.12% to $1.3 billion in 2022, then increased by 2.77% to $1.3 billion in 2023, then grew by 16.3% to $1.5 billion in 2024, then rose by 0.13% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for NHC's Assets are $1.5 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).